Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

被引:0
作者
Lennart Tonneijck
Mark M. Smits
Marcel H. A. Muskiet
Trynke Hoekstra
Mark H. H. Kramer
A. H. Jan Danser
Michaela Diamant
Jaap A. Joles
Daniël H. van Raalte
机构
[1] VU University Medical Center Amsterdam,Department of Internal Medicine/Diabetes Center
[2] VU University Amsterdam,Department of Health Sciences and the EMGO Institute for Health and Care Research
[3] VU University Medical Center,Department of Epidemiology and Biostatistics
[4] Erasmus University Medical Center,Division of Pharmacology and Vascular Medicine, Department of Internal Medicine
[5] University Medical Center,Department of Nephrology and Hypertension
来源
Diabetologia | 2016年 / 59卷
关键词
Diabetes; Exenatide; Glomerular filtration rate; Glomerular hyperfiltration; GLP-1 receptor agonist; Glucagon-like peptide-1; Renal function; Renal haemodynamics; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1412 / 1421
页数:9
相关论文
共 125 条
  • [1] Muskiet MH(2015)Pleiotropic effects of type 2 diabetes management strategies on renal risk factors Lancet Diabetes Endocrinol 3 367-381
  • [2] Tonneijck L(2016)Gastrointestinal actions of GLP-1 based therapies: glycaemic control beyond the pancreas Diabetes Obes Metab 18 224-235
  • [3] Smits MM(2014)The gut-renal axis: do incretin-based agents confer renoprotection in diabetes? Nat Rev Nephrol 10 88-103
  • [4] Smits MM(2012)Exenatide and sitagliptin are not associated with increased risk of acute renal failure: A retrospective claims analysis Diabetes Obes Metab 14 596-600
  • [5] Tonneijck L(2015)Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome N Engl J Med 373 2247-2257
  • [6] Muskiet MH(2004)Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men J Clin Endocrinol Metab 89 3055-3061
  • [7] Muskiet MH(2013)Glucagon-like peptide-1 receptor stimulation increases GFR and suppresses proximal reabsorption in the rat Am J Physiol Renal Physiol 304 F137-F144
  • [8] Smits MM(2013)Glucagon-like peptide-1 (GLP-1): Effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men J Clin Endocrinol Metab 98 664-671
  • [9] Morsink LM(2015)Renal Extraction and Acute Effects of Glucagon-like peptide-1 on Central and Renal Hemodynamics in Healthy Men Am J Physiol Endocrinol 15 E641-E649
  • [10] Diamant M(2016)Acute renal haemodynamic effects of GLP-1 receptor agonist exenatide in healthy overweight males Diabetes Obes Metab 18 178-185